Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
11 April 2024 - 9:30PM
Business Wire
Shaping the Future of Aesthetic Treatments with
Advanced Medical Technology
Apyx® Medical Corporation (NASDAQ:APYX) (the “Apyx Medical”;
“Company”), the manufacturer of a proprietary helium plasma and
radiofrequency technology marketed and sold as Renuvion®, is
pleased to announce the Renuvion Users’ Summit is taking place in
Las Vegas from April 12-13, 2024.
The Renuvion Users’ Summit brings together a diverse group of
dedicated professionals in cosmetic and plastic surgery from 13
countries to share new research, applications, and clinical
experiences with the Company’s Renuvion technology. The insights
and innovation shared at the Renuvion Users’ Summit will help
medical professionals provide the highest level of care for their
patients seeking solutions to improve the appearance of loose skin
through body contouring and other procedures.
The Renuvion Users’ Summit will feature 27 key opinion leader
speakers who bring a deep knowledge and understanding of the
Renuvion technology and how it can be used to enhance outcomes for
patients. New data and research will be presented, with a focus on
body contouring, fat transfer and the safety of Renuvion, including
during the following presentations:
- The Renuvion Effect: Using Ultrasound to Measure Tissue
Contraction
- Scarless Mastopexy: Pearls of Using the Renuvion
Technology
- Enhanced Fat Graft Viability Following Renuvion
Pretreatment
- Renuvion in High-Definition Liposuction: The European Concept
of Beauty
- The Back/Bra Roll: A Consistent and Reproducible Treatment with
Renuvion
“The Renuvion Users’ Summit brings together some of the most
brilliant minds in the cosmetic surgery market, all united with a
single goal – to provide their patients with best-in-class care. It
is designed to support our surgeon customers by providing them with
access to new insights and research related to the use of our
Renuvion technology,” said Charlie Goodwin, President, and CEO of
Apyx Medical Corporation.
“Renuvion has transformed the lives of thousands of patients
seeking solutions for loose skin worldwide,” said Dr. Paul G. Ruff,
board-certified plastic surgeon and clinical research investigator
for Apyx Medical. “The clinical data showcasing Renuvion's safety
and efficacy is unmatched in the category, and the knowledge shared
at the Renuvion Users’ Summit will continue to advance the science
and ultimately benefit patients everywhere.”
Renuvion represents the pinnacle of propriety helium plasma and
radiofrequency technology, designed to achieve tissue contraction
by addressing the problem of loose skin directly at the source,
ultimately providing patients with next level body contouring
results. With six new FDA clearances and three exclusive
indications, including the only post-liposuction use and
subcutaneous tissue contraction clearances, Renuvion continues to
set new standards in safety and performance.
About Apyx Medical Corporation
Apyx Medical Corporation is an advanced energy technology
company with a passion for elevating people’s lives through
innovative products, including its Helium Plasma Technology
products marketed and sold as Renuvion in the cosmetic surgery
market and J-Plasma® in the hospital surgical market. Renuvion and
J-Plasma offer surgeons a unique ability to provide controlled heat
to tissue to achieve their desired results. The effectiveness of
Renuvion and J-Plasma are supported by more than 90 clinical
documents. The Company also leverages its deep expertise and
decades of experience in unique waveforms through OEM agreements
with other medical device manufacturers. For further information
about the Company and its products, please refer to the Apyx
Medical Corporation website at www.ApyxMedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240411056803/en/
Public Relations: Kaplow Communications on behalf of Apyx
Medical Corporation Renuvion@kaplow.com
Investor Relations: ICR Westwicke on behalf of Apyx
Medical Corporation Mike Piccinino, CFA
investor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Dec 2023 to Dec 2024